Senior Associate Vanessa Carle will be participating in Day One of the event on the panel "Charting the Course: The 2024 Investment Landscape for European Biotechs" at the 10th LSX World Congress which takes place on 29 -30 April in London.
The event brings together the CEOs and senior decision makers from the world's most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practice, forge partnerships and investments - all geared at putting capital and ideas to work to help create the world's future medicines and improve patient outcomes. Click here to learn more about registration.